
Global Medical Director, Radiopharma & Imaging
Pentixapharm AG, New Bremen, OH, United States
Medical Director (Global Clinical Development) (m/f/d)
About Us
Pentixapharm AG is a research-driven radiopharmaceutical and precision oncology company focused on developing innovative theranostic therapies. Our clinical-stage programs target the CXCR4 receptor, which plays a key role in aggressive hematologic and solid tumors as well as cardiovascular diseases. We operate in a lean, science-driven biotech environment with a strong focus on execution and accountability.
The Role
We are looking for an experienced Medical Director (Global Clinical Development) to lead the overall medical and clinical strategy for our late-stage development programs, with a strong focus on diagnostic imaging and radiopharmaceutical development.
This role combines strategic leadership with hands-on execution across pivotal clinical trials, regulatory interactions, and benefit–risk assessment in a highly matrixed biotech environment.
Key Responsibilities
Lead overall medical and clinical strategy for late-stage (Phase 2/3 and Phase 3 pivotal) development programs
Provide medical leadership for clinical trial design and execution, including diagnostic and therapeutic radiopharmaceutical studies
Author and review clinical protocols, Clinical IND sections, SAP-relevant sections, and Clinical Study Reports (CSRs)
Oversee benefit–risk assessment and interpretation of diagnostic and imaging performance data
Lead interactions with FDA and EMA, including preparation of briefing books and regulatory responses
Collaborate closely with Regulatory Affairs, Clinical Operations, Biostatistics, Translational Research, and external partners
Provide medical input to development strategy, endpoints, and go/no-go decisions
Your Profile
MD (or equivalent medical degree); background in Radio/Nuclear Medicine or diagnostic imaging strongly preferred
Substantial experience in diagnostic imaging, ideally including PET/CT and molecular imaging
Proven experience leading late-stage oncology or diagnostic development programs
Strong understanding of clinical trial methodology, regulatory expectations, and registrational strategy
Demonstrated direct engagement with FDA and EMA
Ability to combine high-level strategic thinking with hands-on execution
Comfortable working in a lean biotech environment with high accountability
Fluency in English; German is a plus
Why Join Us
High-impact leadership role with strategic ownership of late-stage global programs
Science-driven, collaborative biotech culture with flat hierarchies
Flexible, hybrid working model (Europe or US East Coast)
#J-18808-Ljbffr
#J-18808-Ljbffr